118 related articles for article (PubMed ID: 24678528)
1. A systematic comparative evaluation of 90Y-labeled bifunctional chelators for their use in targeted therapy.
Chakravarty R; Chakraborty S; Dash A
J Labelled Comp Radiopharm; 2014 Feb; 57(2):65-74. PubMed ID: 24678528
[TBL] [Abstract][Full Text] [Related]
2. A systematic study on the utility of CHX-A''-DTPA-NCS and NOTA-NCS as bifunctional chelators for
Pandey U; Gamre N; Lohar SP; Dash A
Appl Radiat Isot; 2017 Sep; 127():1-6. PubMed ID: 28478331
[TBL] [Abstract][Full Text] [Related]
3. Detailed evaluation on the effect of metal ion impurities on complexation of generator eluted 68Ga with different bifunctional chelators.
Chakravarty R; Chakraborty S; Dash A; Pillai MR
Nucl Med Biol; 2013 Feb; 40(2):197-205. PubMed ID: 23218795
[TBL] [Abstract][Full Text] [Related]
4. A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y.
Price EW; Edwards KJ; Carnazza KE; Carlin SD; Zeglis BM; Adam MJ; Orvig C; Lewis JS
Nucl Med Biol; 2016 Sep; 43(9):566-576. PubMed ID: 27419360
[TBL] [Abstract][Full Text] [Related]
5. Preparation of
Pandey U; Kameswaran M; Gamre N; Dash A
J Labelled Comp Radiopharm; 2019 Apr; 62(4):158-165. PubMed ID: 30663095
[TBL] [Abstract][Full Text] [Related]
6. Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability.
Cooper MS; Ma MT; Sunassee K; Shaw KP; Williams JD; Paul RL; Donnelly PS; Blower PJ
Bioconjug Chem; 2012 May; 23(5):1029-39. PubMed ID: 22471317
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals.
Ferreira CL; Lamsa E; Woods M; Duan Y; Fernando P; Bensimon C; Kordos M; Guenther K; Jurek P; Kiefer GE
Bioconjug Chem; 2010 Mar; 21(3):531-6. PubMed ID: 20175523
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of novel ligands for radioimmunotherapy.
Chong HS; Milenic DE; Garmestani K; Brady ED; Arora H; Pfiester C; Brechbiel MW
Nucl Med Biol; 2006 May; 33(4):459-67. PubMed ID: 16720237
[TBL] [Abstract][Full Text] [Related]
9. Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478.
Lee FT; Mountain AJ; Kelly MP; Hall C; Rigopoulos A; Johns TG; Smyth FE; Brechbiel MW; Nice EC; Burgess AW; Scott AM
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7080s-7086s. PubMed ID: 16203806
[TBL] [Abstract][Full Text] [Related]
10. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of
Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A
Cancer Biother Radiopharm; 2018 Feb; 33(1):8-16. PubMed ID: 29373046
[TBL] [Abstract][Full Text] [Related]
11. Yttrium-90-labeled human macroaggregated albumin for internal radiotherapy: combined use with DTPA.
Watanabe N; Oriuchi N; Endo K; Inoue T; Tanada S; Murata H; Sasaki Y
Nucl Med Biol; 1999 Oct; 26(7):847-51. PubMed ID: 10628567
[TBL] [Abstract][Full Text] [Related]
12. Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide.
Clifford T; Boswell CA; Biddlecombe GB; Lewis JS; Brechbiel MW
J Med Chem; 2006 Jul; 49(14):4297-304. PubMed ID: 16821789
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies.
Camera L; Kinuya S; Garmestani K; Wu C; Brechbiel MW; Pai LH; McMurry TJ; Gansow OA; Pastan I; Paik CH
J Nucl Med; 1994 May; 35(5):882-9. PubMed ID: 8176477
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of [(111/114m)In]CHX-A''-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors.
Orlova A; Rosik D; Sandström M; Lundqvist H; Einarsson L; Tolmachev V
Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):314-23. PubMed ID: 17464277
[TBL] [Abstract][Full Text] [Related]
15. Physical parameters and biological stability of yttrium(III) diethylenetriaminepentaacetic acid derivative conjugates.
McMurry TJ; Pippin CG; Wu C; Deal KA; Brechbiel MW; Mirzadeh S; Gansow OA
J Med Chem; 1998 Aug; 41(18):3546-9. PubMed ID: 9719608
[TBL] [Abstract][Full Text] [Related]
16. Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.
Sun X; Wuest M; Weisman GR; Wong EH; Reed DP; Boswell CA; Motekaitis R; Martell AE; Welch MJ; Anderson CJ
J Med Chem; 2002 Jan; 45(2):469-77. PubMed ID: 11784151
[TBL] [Abstract][Full Text] [Related]
17. A novel bifunctional maleimido CHX-A'' chelator for conjugation to thiol-containing biomolecules.
Xu H; Baidoo KE; Wong KJ; Brechbiel MW
Bioorg Med Chem Lett; 2008 Apr; 18(8):2679-83. PubMed ID: 18359632
[TBL] [Abstract][Full Text] [Related]
18. p-NO
Spreckelmeyer S; Ramogida CF; Rousseau J; Arane K; Bratanovic I; Colpo N; Jermilova U; Dias GM; Dude I; Jaraquemada-Peláez MG; Bénard F; Schaffer P; Orvig C
Bioconjug Chem; 2017 Aug; 28(8):2145-2159. PubMed ID: 28683198
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the in vivo biodistribution of yttrium-labeled isomers of CHX-DTPA-conjugated monoclonal antibodies.
Kobayashi H; Wu C; Yoo TM; Sun BF; Drumm D; Pastan I; Paik CH; Gansow OA; Carrasquillo JA; Brechbiel MW
J Nucl Med; 1998 May; 39(5):829-36. PubMed ID: 9591585
[TBL] [Abstract][Full Text] [Related]
20. Reduction of skeletal accumulation of radioactivity by co-injection of DTPA in [90Y-DOTA0,Tyr3]octreotide solutions containing free 90Y3+.
Breeman WA; De Jong MT; De Blois E; Bernard BF; De Jong M; Krenning EP
Nucl Med Biol; 2004 Aug; 31(6):821-4. PubMed ID: 15246375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
